Vox Sanguinis International Forum on platelet cryopreservation

Vox Sanguinis

Volumn 112, Issue 7, 2017, Pages e69-e85

  Cohn, C S ^u   Dumont, L J ^u   Lozano, M ^u   Marks, D C ^a   Johnson, L ^a   Ismay, S ^a   Bondar, N ^a   T'Sas, F ^b   Yokoyama, A P H ^c   Kutner, J M ^c   Acker, J P ^d   Bohonek, M ^e   Sailliol, A ^f   Martinaud, C ^f   Poglod R ^g   Antoniewicz Papis, J ^g   Lachert, E ^g   Pun, P B L ^h   Lu, J ^h   Cid, J ⁱ   Guijarro, F ^j   Puig, L ^k   Gerber, B ^l   Alberio, L ^m   Schanz, U ⁿ   Buser, A ^o   Noorman, F ^p   Zoodsma, M ^p   van der Meer, P F ^q   de Korte, D ^r   Wagner, S ^s   O'Neill, M ^t   more..

^a Australian Red Cross Blood Service   (Australia)

^b HMRA Service Militaire de Transfusion Sanguine   (Belgium)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d CANADIAN BLOOD SERVICES   (Canada)

^e CHARLES UNIVERSITY   (Czech Republic)

^f French Military Blood Bank (CTSA)   (France)

^g INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^h DSO NATIONAL LABORATORIES   (Singapore)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j UNIVERSITY OF BARCELONA   (Spain)

^k BANC DE SANG I TEIXITS   (Spain)

^l ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o UNIVERSITY HOSPITAL BASEL   (Switzerland)

^p Military Blood Bank   (Netherlands)

^q CENTRAL LABORATORY   (Netherlands)

^r Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

^s HOLLAND LABORATORY   (United States)

^t AMERICAN RED CROSS   (United States)

^u American Red Cross Medical Office ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

BLOOD BANK; COST; CRYOPRESERVATION; FREEZE DRYING; FREEZING; GOOD MANUFACTURING PRACTICE; LETTER; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHELF LIFE; THAWING; THROMBOCYTE;

EID: 85030257565     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12532     Document Type: Letter

References (39)

1. Reade MC, Marks DC, Johnson L, et al.: Frozen platelets for rural Australia: the CLIP trial. Anaesth Intensive Care 2013; 41:804–805
2. Johnson L, Reade MC, Hyland RA, et al.: In vitro comparison of cryopreserved and liquid platelets: potential clinical implications. Transfusion 2015; 55:838–847
3. Johnson L, Coorey CP, Marks DC: The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion 2014; 54:1917–1926
4. Johnson L, Tan S, Wood B, et al.: Refrigeration and cryopreservation of platelets differentially affect platelet metabolism: a comparison with conventional platelet storage conditions. Transfusion 2016; 56:1807–1818. https://doi.org/10.1111/trf.13630
5. Valeri CR, Ragno G, Khuri S: Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at −80 degrees C without postthaw processing. Transfusion 2005; 45:1890–98
6. Nasiri S: Infusible platelet membrane as a platelet substitute for transfusion: an overview. Blood Transfus 2013; 11:337–42
7. Norman F, Badloe JF: 80°C Frozen red blood cells, plasma and platelets, efficient logistics, available, compatible, safe and effective in the treatment of trauma patients with or without massive blood loss in military theatre. Poster presented at AABB meeting, Boston, USA, Oct. 2012
8. Valeri CR, Rango G, Khuru S: Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at −80°C without postthaw processing. Transfusion 2005; 45:1890–1898
9. Bohonek M, Landova L: Frozen platelets as an easy available alternative in blood components supply, poster presented at 25th Regional Congress of the ISBT, London, UK, June 2015
10. Norman F, Strelitski R, Badloe JF: -80°C Frozen platelets are activated compared to 24 hour liquid-stored platelets and quality of frozen platelets is unaffected by a quick preparation method (15 min) which can be used to prepare platelets for the early treatment of trauma patients in military theatre, Poster presented at AABB meeting, Boston, USA, Oct. 2012
11. Johnson LN, Reid SJ, Winter KM, et al.: The Australian experience with deep frozen blood products, Johnson, poster presented at 32rd International Congress of the ISBT, Cancun, Mexico, July 2012
12. Dumont LJ, Cancelas JA, Dumont DF, et al.: A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide–frozen autologous platelets in healthy volunteers. Transfusion 2013; 53:128–137
13. ANSM: recommandations_-_transfusion_de_plaquettes. 2016: 1–50
14. Lelkens CCM, Koning JG, de Kort B, Floot IBG, Noorman F: Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006; 34:289–98
15. Journal officiel de la République française - N° 276 du 28 novembre 2010. 2010: 1–44
16. Macko AR, Crossland RF, Cap AP, Fryer DM, Mitchell TA, Pusateri AE, Sheppard FR: Control of severe intra-abdominal hemorrhage with an infusible platelet-derived hemostatic agent in a nonhuman primate (rhesus macaque) model. J Trauma Acute Care Surg 2016; 80:617–24
17. Łętowska M (ed): Medyczne zasady pobierania krwi, oddzielania jej składników i wydawania, obowiązujące w jednostkach organizacyjnych publicznej służby krwi. Warszawa, Instytut Hematologii i Transfuzjologii, 2014
18. Sanz C, Ghita G, Franquet C, Martinez I, Pereira A: Red-blood-cell alloimmunization and female sex predict the presence of HLA antibodies in patients undergoing liver transplant. Vox Sang 2010; 99:261–266
19. Valeri CR, Feingold H, Marchionni LD: A simple method for freezing human platelets using 6 per cent dimethylsulfoxide and storage at -80 degrees C. Blood 1974; 43:131–136
20. Valeri CR, Ragno G, Khuri S: Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing. Transfusion 2005; 45:1890–1898
21. Valeri CR, Srey R, Lane JP, Ragno G: Effect of WBC reduction and storage temperature on PLTs frozen with 6 percent DMSO for as long as 3 years. Transfusion 2003; 43:1162–1167
22. Weber T, Marino IR, Kang YG, Esquivel CD, Starzl TE, Duquesnoy RJ: Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 1989; 47:797–801
23. Modery-Pawlowski CL, Tian LL, Pan V, McCrae KR, Mitragotri S, Sen GA: Approaches to synthetic platelet analogs. Biomaterials 2013; 34:526–541
24. Gerber B, Alberio L, Stenner F, Buser A, Schanz U, Stussi G: Transfusion of cryopreserved autologous platelets to overcome HLA alloimmunization in patients with hematological malignancies. Blood 2011; 118:3375
25. Gerber B, Alberio L, Rochat S, et al.: Safety and efficacy of cryopreserved autologous platelet concentrates in HLA alloimmunized patients with hematological malignancies. Transfusion 2016; 56:2426–37
26. Arber C, Bertrand G, Halter J, Boehlen F, Kaplan C, Gratwohl A: Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay. Br J Haematol 2007; 139:159–61
27. Lelkens CC, Koning JG, de Kort B, et al.: Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006; 34:289–98
28. Noorman F, Strelitski R, Badloe JF: Frozen platelets can be stored for 4 years at -80°C without affecting in vitro recovery, morphology, receptor expression and coagulation profile. Transfusion 2014; 54(Suppl):74A
29. Noorman F, Strelitski R., Badloe JF: -80°C Frozen platelets are activated compared to 24 hour liquid-stored platelets and quality of frozen platelets is unaffected by a quick preparation method (15 min) which can be used to prepare platelets for the early treatment of trauma patients in military theatre. Transfusion 2012; 52(Suppl S3):33A
30. Noorman F, van Dongen TTCF, Plat MJ, et al.: Transfusion: −80°C Frozen blood products are safe and effective in military casualty care. Plos One 2016. https://doi.org/10.1371/journal.pone.0168401
31. Windelov NA, Johansson PI, Sorensen AM, et al.: Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients. J Trauma Acute Care Surg 2014; 77:692–700
32. Matijevic N, Wang YW, Holcomb JB, et al.: Microvesicle phenotypes are associated with transfusion requirements and mortality in subjects with severe injuries. J Extracell Vesicles 2015; 4:29338
33. Dijkstra-Tiekstra MJ, de Korte D, Pietersz RN, et al.: Comparison of various dimethylsulphoxide-containing solutions for cryopreservation of leucoreduced platelet concentrates. Vox Sang 2003; 85:276–282
34. Cid J, Escolar G, Galan A, et al.: In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets. Transfusion 2016; 56:580–586
35. Dumont LJ, Cancelas JA, Dumont DF, et al.: A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide-frozen autologous platelets in healthy volunteers. Transfusion 2013; 53:128–137
36. Tegegn TZ, De Paoli SH, Orecna M, et al.: Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets. J Extracell Vesicles 2016; 5:30422
37. Cid J, Escolar G, Galan A, et al.: In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets. Transfusion 2016; 56:580–6
38. Khuri SF, Heaaley N, Macgregor H, et al.: Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 117:172–83
39. Fitzpatrick GM, Cliff R, Tandon N: Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage. Transfusion 2013; 53(Suppl 1):100S–106S